Loomis, Sayles & Company’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
Other funds holding SBRA
CIM
Loomis, Sayles & Company's SBRA Position: Q2 2019 in Review
Loomis, Sayles & Company sold out of Sabra Healthcare REIT (SBRA) in Q2 2019, closing a stake of 370,605 shares — an estimated $7.22M sold.
Loomis, Sayles & Company first reported a position in SBRA in Q2 2013 and held it in 24 quarters. The position peaked at $42.3M in Q1 2015. 309 funds tracked by Wall St. Rank hold SBRA as of Q2 2019.
- Loomis, Sayles & Company reported no remaining Sabra Healthcare REIT position as of Q2 2019 after selling out during the quarter.
- Loomis, Sayles & Company sold 370,605 Sabra Healthcare REIT shares in Q2 2019, an estimated $7.22M.
- Loomis, Sayles & Company first reported a position in Sabra Healthcare REIT in Q2 2013 and held it in 24 quarters.
- Loomis, Sayles & Company's Sabra Healthcare REIT position peaked at $42.3M in Q1 2015.
- 309 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2019.
Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.